seeing green

Houston continues its reign as the top city using renewables, per the EPA

The City of Houston has held the No. 1 spot on the municipal list since 2014. Photo via Getty Images

The City of Houston continues to electrify the country when it comes to the use of green power.

The U.S. Environmental Protection Agency (EPA) ranks the city first among municipal entities for the highest annual consumption of power from renewable sources. The list features participants in the EPA's Green Energy Partnership.

The EPA pegs the City of Houston's annual use of green power at a little over 1 billion kilowatt-hours. That's enough electricity to power more than 94,000 average U.S. homes in a year's time. No other municipal entity uses more than 1 billion kilowatt-hours of green power per year.

The City of Houston has held the No. 1 spot on the municipal list since 2014. Among all users of green power in the U.S. that participate in the EPA's Green Energy Partnership, the city ranks 19th.

Since July 2020, all City of Houston facilities have been powered by 100 percent renewable energy derived from solar and wind sources. Houston-based NRG supplies the electricity for those facilities.

In an August 11 news release, Houston Mayor Sylvester Turner says the EPA recognition is "great news for the city of Houston and, by extension, for the rest of the world. We are going big to set the example for cities around the world. If 100 percent renewable energy can happen in Houston, it can happen in any other city."

The news release points out that green power helps offset damage from ozone, acid rain, haze, fine particles, and other harmful pollutants. Fine particles come primarily from exhaust produced by vehicles, as well as from the burning of coal, wood, and heating oil, and from forest fires and grass fires.

The City of Houston isn't the only municipal outfit in Texas that shines on the EPA list. Here's are four others among the top 30 municipal users of green power:

  • City of Dallas, ranked second, 701.8 million kilowatt-hours of green power used each year.
  • Dallas-Fort Worth International Airport, ranked fifth, 450.2 million kilowatt-hours of green power used each year.
  • City of Austin, ranked sixth, 325.3 million kilowatt-hours of green power used each year.
  • City of Irving, ranked 30th, 24.9 million kilowatt-hours of green power used each year.

Nationally, these five Texas businesses rank among the top corporate users of green power:

  • Dallas-based AT&T, ranked seventh, 2.36 billion kilowatt-hours of green power used each year.
  • Irving-based Kimberly-Clark, ranked 18th, 1.03 billion kilowatt-hours of green power used each year.
  • Round Rock-based Dell, ranked 46th, 365.6 million kilowatt-hours of green power used each year.
  • Houston-based Solvay America, ranked 61st, 220 million kilowatt-hours of green power used each year.
  • Plano-based Cinemark USA, ranked 95th, 120.2 million kilowatt-hours of green power used each year.

Two Texas schools appear on the list of the top colleges and universities for use of green power:

  • University of North Texas in Denton, ranked 17th, 80.3 million kilowatt-hours of green power used each year.
  • Fort Worth-based Tarrant County College District, ranked 25th, 57.1 million kilowatt-hours of green power used each year.

Four Texas institutions show up on the list of the top K-12 users of green power:

  • Austin ISD, ranked second, 19.8 million kilowatt-hours of green power used each year.
  • Lake Travis ISD (select schools), ranked 12th, 960,000 kilowatt-hours of green power used each year.
  • The da Vinci School in Dallas, ranked 15th, 237,990 kilowatt-hours of green power used each year.
  • The Empower School in Austin, ranked 17th, 115,314 kilowatt-hours of green power used each year.

The EPA's ranking of the largest users of green power across the country "is proof that good business practices can also benefit the environment," says James Critchfield, director of the EPA's Green Power Partnership.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted